Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qsymia in Binge Eating Disorder
NCT02659475Phase 2Completed
- Sponsor
- Lindner Center of HOPE
- Start
- Sep 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of phentermine + topiramate in binge eating disorder (BED), sponsored by Lindner Center of HOPE. Started Sep 2015; status: completed.
02
Drugs
phentermine + topiramate
03
Conditions
binge eating disorder (BED)
Beyond the preview
Go deeper on NCT02659475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02659475.